TERM LOAN CREDIT AGREEMENT Dated as of December 29, 2008, among KING PHARMACEUTICALS, INC., as Borrower, THE LENDERS PARTY HERETO and CREDIT SUISSE, as Administrative Agent and as Collateral Agent CREDIT SUISSE SECURITIES (USA) LLC and WACHOVIA...Term Loan Credit Agreement • March 2nd, 2009 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
TERM LOAN CREDIT AGREEMENT dated as of December 29, 2008 (as amended, supplemented or otherwise modified from time to time, this “Agreement”) among KING PHARMACEUTICALS, INC., a Tennessee corporation (the “Borrower”), the Lenders (such term and each other capitalized term used but not defined in this introductory statement having the meaning given it in Article 1), and CREDIT SUISSE, as administrative agent (in such capacity, including any successor thereto, the “Administrative Agent”) and as collateral agent (in such capacity, including any successor thereto, the “Collateral Agent”) for the Lenders.
AMENDMENT NO. 1 TO CREDIT AGREEMENTCredit Agreement • March 2nd, 2009 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT dated as of April 19, 2007 as amended by Amendment No. 1 dated December 5, 2008 (as further amended, supplemented or otherwise modified from time to time, this “Agreement”), among KING PHARMACEUTICALS, INC., a Tennessee corporation (the “Borrower”); the Lenders (as defined in Article I); CREDIT SUISSE, a bank organized under the laws of Switzerland, acting through its Cayman Islands Branch, as administrative agent and collateral agent for the Lenders (in such capacity, the “Administrative Agent” and the “Collateral Agent”), and as swingline lender (in such capacity, the “Swingline Lender”), Bank of America, N.A. and UBS Securities LLC, as co-syndication agents (in such capacity, “Co-Syndication Agents”); Citigroup Global Markets Inc., Wachovia Bank, National Association and The Royal Bank of Scotland plc, as co-documentation agents (in such capacity, the “Co-Documentation Agents”); U.S. Bank National Association, as managing agent (in such capacity, the “Managing Agent
ASSET PURCHASE AGREEMENT by and between KING PHARMACEUTICALS, INC. and ACTAVIS ELIZABETH, L.L.C. dated as of December 17, 2008Asset Purchase Agreement • March 2nd, 2009 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Asset Purchase Agreement (this “Agreement”) is made and entered into as of December 17, 2008 (the “Execution Date”), by and between Actavis Elizabeth, L.L.C., a Delaware limited liability company (“Buyer”), and King Pharmaceuticals, Inc., a Tennessee corporation (“King”).
